Amgen AMGN reported third-quarter 2020 earnings of $4.37 per share, which beat the Zacks Consensus Estimate of $3.75. Earnings rose 19% year over year driven by higher revenues. Total revenues of ...
Dr. Reddy’s and Alvotech have entered into a license and supply agreement for the commercialization of AVT03, Alvotech’s biosimilar candidate to Prolia and Xgeva (denosumab). The collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback